Literature DB >> 14738446

Generation of B220low B cells and production of autoantibodies in mice with experimental amyloidosis: association of primordial T cells with this phenomenon.

S Kawabe1, T Abe, H Kawamura, F Gejyo, T Abo.   

Abstract

To investigate the immunological state in amyloidosis, mice were twice intraperitoneally injected (2-week interval) with casein emulsified in complete Freund's adjuvant. Two weeks after the treatment, amyloid deposits were detected in the spleen and other organs of these mice. The number of lymphocytes yielded by the liver and spleen increased significantly. The most affected lymphocyte subset was found to be B cells, namely, the total number of B cells increased and unusual B220low B cells were newly generated in the liver and spleen. In other words, not only normal B220high B cells but also unusual B220low B cells were detected in these organs of mice with amyloidosis. In parallel with this phenomenon, autoantibodies against denatured DNA were detected in sera. Since such autoantibodies are known to accompany the functional activation of NKT cells, NKT cell-deficient mice were used for the induction of amyloidosis. Such mice showed less formation of amyloidosis and lower levels of autoantibodies in sera. Athymic nude mice were NKT cell-deficient but NK1.1- TCRint cells were present. These athymic mice showed an intermediate induction of amyloidosis. The cytokine profile seen in mice with amyloidosis was the Th0 type, showing simultaneous production of IL-4 and IFNgamma. These results suggest that the generation of B220low B cells and the production of autoantibodies in aid of primordial T cells may be major immunological mechanisms in amyloidosis mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738446      PMCID: PMC1808931          DOI: 10.1111/j.1365-2249.2003.02361.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Quick recovery in the generation of self-reactive CD4low natural killer (NK) T cells by an alternative intrathymic pathway when restored from acute thymic atrophy.

Authors:  S Maruyama; A Tsukahara; S Suzuki; T Tada; M Minagawa; H Watanabe; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

2.  Resistance of extrathymic T cells to stress and the role of endogenous glucocorticoids in stress associated immunosuppression.

Authors:  T Shimizu; T Kawamura; C Miyaji; H Oya; M Bannai; S Yamamoto; A Weerasinghe; R C Halder; H Watanabe; K Hatakeyama; T Abo
Journal:  Scand J Immunol       Date:  2000-03       Impact factor: 3.487

3.  Thymic dependence of invariant V alpha 14+ natural killer-T cell development.

Authors:  F Tilloy; J P Di Santo; A Bendelac; O Lantz
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

4.  Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.

Authors:  M K Mannoor; A Weerasinghe; R C Halder; S Reza; M Morshed; A Ariyasinghe; H Watanabe; H Sekikawa; T Abo
Journal:  Cell Immunol       Date:  2001-08-01       Impact factor: 4.868

5.  Cervical spine in patients with juvenile chronic arthritis and amyloidosis.

Authors:  K Laiho; S Hannula; A Savolainen; H Kautiainen; M Kauppi
Journal:  Clin Exp Rheumatol       Date:  2001 May-Jun       Impact factor: 4.473

6.  Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis.

Authors:  O Kaipiainen-Seppänen; R Myllykangas-Luosujärvi; E Lampainen; R Ikäheimo
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

7.  Intensive generation of NK1.1- extrathymic T cells in the liver by injection of bone marrow cells isolated from mice with a mutation of polymorphic major histocompatibility complex antigens.

Authors:  R C Halder; T Kawamura; M Bannai; H Watanabe; H Kawamura; M K Mannoor; S R Morshed; T Abo
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

8.  Three day neonatal thymectomy selectively depletes NK1.1+ T cells.

Authors:  K Hammond; W Cain; I van Driel; D Godfrey
Journal:  Int Immunol       Date:  1998-10       Impact factor: 4.823

9.  NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.

Authors:  M C Coles; D H Raulet
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

10.  Essential role of extrathymic T cells in protection against malaria.

Authors:  M Kaiissar Mannoor; Ramesh C Halder; Sufi Reza M Morshed; Anoja Ariyasinghe; Hanaa Y Bakir; Hiroki Kawamura; Hisami Watanabe; Hiroho Sekikawa; Toru Abo
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

View more
  5 in total

Review 1.  Biology of autoreactive extrathymic T cells and B-1 cells of the innate immune system.

Authors:  Toru Abo; Chikako Tomiyama; Hisami Watanabe
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 2.  Immunologic states of autoimmune diseases.

Authors:  Toru Abo; Toshihiko Kawamura; Hisami Watanabe
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Appearance of B220low autoantibody-producing B-1 cells at neonatal and older stages in mice.

Authors:  S Tachikawa; T Kawamura; H Kawamura; Y Kanda; Y Fujii; H Matsumoto; T Abo
Journal:  Clin Exp Immunol       Date:  2008-07-18       Impact factor: 4.330

4.  Coincidence of autoantibody production with the activation of natural killer T cells in α-galactosylceramide-mediated hepatic injury.

Authors:  Hiroaki Matsumoto; Toshihiko Kawamura; Takahiro Kobayashi; Yasuhiro Kanda; Hiroki Kawamura; Toru Abo
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

5.  Differential immune response associated to malaria outcome is detectable in peripheral blood following Plasmodium yoelii infection in mice.

Authors:  Isabel G Azcárate; Patricia Marín-García; Alí N Kamali; Susana Pérez-Benavente; Antonio Puyet; Amalia Diez; José M Bautista
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.